Skip to main content
. Author manuscript; available in PMC: 2014 Feb 19.
Published in final edited form as: Am J Kidney Dis. 2013 May 16;62(2):201–213. doi: 10.1053/j.ajkd.2013.03.018
  • 6.1

    We recommend that in children with CKD ND, BP-lowering treatment is started when BP is consistently above the 90th percentile for age, sex, and height. (1C)

  • 6.2

    We suggest that in children with CKD ND (particularly those with proteinuria), BP is lowered to consistently achieve systolic and diastolic readings less than or equal to the 50th percentile for age, sex, and height, unless achieving these targets is limited by signs or symptoms of hypotension. (2D)

  • 6.3

    We suggest that an ARB or ACE-I be used in children with CKD ND in whom treatment with BP-lowering drugs is indicated, irrespective of the level of proteinuria. (2D)

Abbreviations: ACE-I, angiotensin-converting enzyme inhibitor(s); ARB, angiotensin-receptor blocker; BP, blood pressure; CKD, chronic kidney disease; ND, non–dialysis-dependent.

Reproduced with permission of KDIGO from the KDIGO Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease.1